The value of serial MR imaging in the assessment of brain metastases volume control during stereotactic radiosurgery

Risultato della ricerca: Other

Abstract

Purpose: To evaluate early tumour control capabilities of Stereotactic Radiosurgery (SRS) in the treatment of brain metastasis and the role of follow-up MR imaging.Methods and Materials: MR imaging of 54 metastases in 31 patients treated with SRS who underwent follow-up MR imaging within 12 months were retrospectively reviewed. Tumours were characterized as either enlarged (>20% volume increase), stable (follow-up volume ±20% of the initial volume), or decreased (> 0% volume decrease).Results: Within the first 6 weeks following SRS a decrease was observed in 25 (52%) of the tumours in the extent of 63% in size. Tumour reduction varied according to histopathological subtype with 38% of non-small cell lung carcinomas, 41% of breast carcinomas, 14% renal cell carcinoma and 8% of melanomas. At 9 weeks, 7 out of the 25 lesions had a transient tumour volume increase followed by tumour regression at 12 weeks. At 12 months 19 (37%) of lesions increased in volume in the extent of 41% in size. There was a significant higher tumour reduction in those carcinoma types that are considered as radiation sensitive. The best timing for follow-up imaging is at 6, 9 and 12 weeks to provide clinicians useful information.Conclusion: Stereotactic radiosurgery provide volume reduction in many brain metastases and it may be used alone or before whole brain radiation therapy to early tumour control. Follow-up MR imaging provide clinicians useful patient information aimed to make treatment decisions.
Lingua originaleEnglish
Numero di pagine1
Stato di pubblicazionePublished - 2015

Fingerprint Entra nei temi di ricerca di 'The value of serial MR imaging in the assessment of brain metastases volume control during stereotactic radiosurgery'. Insieme formano una fingerprint unica.

Cita questo